Treating COVID-19 with Paxlovid. What are the pros and cons?

A Pfizer lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany (Suppled - Pfizer).

Source: Supplied: Pfizer

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus. But since its approval, there have been questions about why it takes so long to make Paxlovic.


While the time frame to make the pill isn't unusual, some people are wondering if and when supplies will improve.  How does this impact on those vulnerable to COVID-19?
And you can keep abreast of the latest information about the corona virus in your language at sbs.com.au/coronavirus


Share
Follow SBS Indonesian

Download our apps
SBS Audio
SBS On Demand

Listen to our podcasts
Independent news and stories connecting you to life in Australia and Indonesian-speaking Australians.
Ease into the English language and Australian culture. We make learning English convenient, fun and practical.
Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS
SBS Indonesian News

SBS Indonesian News

Watch it onDemand